<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04120259</url>
  </required_header>
  <id_info>
    <org_study_id>002</org_study_id>
    <nct_id>NCT04120259</nct_id>
  </id_info>
  <brief_title>Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics</brief_title>
  <official_title>Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics:A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ziauddin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ziauddin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      `This study aims to compare the effect of Metformin alone vs Metformin plus Apple Cider
      Vinegar in newly diagnosed Type 2 Diabetic Patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetes Mellitus is one of the oldest diseases known to men and has been treated with
      multiple agents,organic and with the current pharmacological advancement,with multiple
      synthetic drugs as well.

      Metformin has been considered first line for the treatment of Type 2 Diabetes, however
      presents itself with a side effect profile of GI distress, Vitamin B12 deficiency,to name a
      few.

      Vinegar has been used as therapeutic agent for centuries for multiple ailments including
      diabetes. This study aims to evaluate the combined effects of drug and natural therapy and
      compare it with conventional therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 22, 2019</start_date>
  <completion_date type="Actual">August 26, 2019</completion_date>
  <primary_completion_date type="Actual">August 26, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BMI (Anthropometric Measurement)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body Mass Index: A measure of obesity calculated as weight in kilograms divided by height in meters square</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of Hemoglobin A1c</measure>
    <time_frame>12 weeks</time_frame>
    <description>A blood test for Glycated Hemoglobin that represents a 2-3 month glycemic control</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of Fasting Blood Sugar</measure>
    <time_frame>12 weeks</time_frame>
    <description>A blood test that involves the measurement of plasma glucose after 8 to 12 hours of fasting</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention: Metformin Tablet oral 750 mg OD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Metformin 750 mg oral plus 2 tablespoons of apple cider vinegar OD</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin Oral Tablet</intervention_name>
    <description>A biguanide drug used as a first line therapy for Diabetes MellitusType 2</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vinegar</intervention_name>
    <description>A common herbal/dietary supplement used for centuries as an anti bacterial, cleaning,cooking, anti diabetic agent, to name a few uses.</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recently diagnosed Type 2 diabetic patients taking metformin 750 mg daily as the oral
             antidiabetic agent

          -  Patients with Hemoglobin A1c in the range of 6.5 to 7.5%

        Exclusion Criteria:

          -  All newly diagnosed Diabetic Patients requiring a dosage other than 750 mg per day

          -  Patients on Insulin Therapy or any drugs for diabetes other than Metformin

          -  Pregnant and Lactating women

          -  Patients with food allergies to either apple or any source of vinegar

          -  Patients unable to communicate efficiently\mentally challenged

          -  Type 2 Diabetic patients with any of the complications of long standing uncontrolled
             diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr Momina Abid, MBBS,M Phil (ongoing)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ziauddin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr Zahida Memon, MBBS,M Phil,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ziauddin University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ziauddin University</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>7500</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 7, 2019</study_first_submitted>
  <study_first_submitted_qc>October 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2019</study_first_posted>
  <last_update_submitted>October 17, 2019</last_update_submitted>
  <last_update_submitted_qc>October 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ziauddin University</investigator_affiliation>
    <investigator_full_name>Dr Momina Abid</investigator_full_name>
    <investigator_title>Dr Momina Abid</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Acetic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

